E61: Erik Iverson and Mike Partsch on WARF’s $3B Endowment Strategy
Erik Iverson and Mike Partsch of the Wisconsin Alumni Research Foundation (WARF) sit down with David Weisburd to discuss how WARF supports innovation while driving financial returns. In addition, they discuss the case for investing in life sciences, how inventions turn into portfolio companies and the importance of maintaining relationships through market cycles.
Key Points
- Venture capital is essential for a well-balanced portfolio due to its high-risk, high-reward nature, and it often rebounds stronger after down cycles.
- WARF's private equity strategy focuses heavily on life sciences, leveraging relationships with top-tier funds to support spinout companies from the University of Wisconsin.
- Establishing relationships with GPs through co-investing in deals helps WARF evaluate the long-term behavior and alignment of interests of potential venture partners.
Chapters
0:00 | |
1:18 | |
4:08 | |
7:00 | |
10:03 | |
12:45 | |
17:04 | |
18:47 |
Transcript
Loading transcript...
- / -